TY - JOUR
T1 - Dietary iron restriction prevents further deterioration of renal damage in a chronic kidney disease rat model
AU - Naito, Yoshiro
AU - Fujii, Aya
AU - Sawada, Hisashi
AU - Hirotani, Shinichi
AU - Iwasaku, Toshihiro
AU - Okuhara, Yoshitaka
AU - Eguchi, Akiyo
AU - Ohyanagi, Mitsumasa
AU - Tsujino, Takeshi
AU - Masuyama, Tohru
PY - 2013/6
Y1 - 2013/6
N2 - Objective: Iron accumulation is associated with the pathogenesis of chronic kidney disease (CKD). However, little is known about the effects of isolated iron restriction against CKD. We have recently reported that iron restriction prevents the development of renal damage in the well established 5/6 nephrectomy rat model of CKD. Herein, we investigated the therapeutic effects of iron restriction on preexisting hypertension and renal damage in a rat model of CKD. Methods: CKD was induced by 5/6 nephrectomy in Sprague-Dawley rats. After surgery, 5/6 nephrectomized rats were given an iron-restricted diet from 1 day to 16 weeks for prevention protocol or from 8 to 16 weeks for rescue protocol. Other CKD rats were given a normal diet. Results: At 16 weeks after surgery, CKD rats developed hypertension and renal damage. Early intervention with iron restriction prevented the development of hypertension and vascular remodeling. By contrast, late intervention with iron restriction did not remarkably ameliorate preexisting hypertension and vascular remodeling in CKD rats. On the contrary, late intervention with iron restriction prevented further progression of preexisting renal damage in CKD rats. Interestingly, iron restriction led to increased urinary sodium and decreased urinary potassium excretions in CKD rats. Moreover, iron restriction markedly attenuated renal expression of nuclear mineralocorticoid receptor and Rac1 activity in CKD rats. Conclusion: Iron restriction prevented further deterioration of preexisting renal damage. The beneficial effects of iron restriction on renal damage seem to be associated with inhibition of renal mineralocorticoid receptor signaling.
AB - Objective: Iron accumulation is associated with the pathogenesis of chronic kidney disease (CKD). However, little is known about the effects of isolated iron restriction against CKD. We have recently reported that iron restriction prevents the development of renal damage in the well established 5/6 nephrectomy rat model of CKD. Herein, we investigated the therapeutic effects of iron restriction on preexisting hypertension and renal damage in a rat model of CKD. Methods: CKD was induced by 5/6 nephrectomy in Sprague-Dawley rats. After surgery, 5/6 nephrectomized rats were given an iron-restricted diet from 1 day to 16 weeks for prevention protocol or from 8 to 16 weeks for rescue protocol. Other CKD rats were given a normal diet. Results: At 16 weeks after surgery, CKD rats developed hypertension and renal damage. Early intervention with iron restriction prevented the development of hypertension and vascular remodeling. By contrast, late intervention with iron restriction did not remarkably ameliorate preexisting hypertension and vascular remodeling in CKD rats. On the contrary, late intervention with iron restriction prevented further progression of preexisting renal damage in CKD rats. Interestingly, iron restriction led to increased urinary sodium and decreased urinary potassium excretions in CKD rats. Moreover, iron restriction markedly attenuated renal expression of nuclear mineralocorticoid receptor and Rac1 activity in CKD rats. Conclusion: Iron restriction prevented further deterioration of preexisting renal damage. The beneficial effects of iron restriction on renal damage seem to be associated with inhibition of renal mineralocorticoid receptor signaling.
KW - chronic kidney disease
KW - hypertension
KW - iron
KW - mineralocorticoid receptor
UR - http://www.scopus.com/inward/record.url?scp=84877584908&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84877584908&partnerID=8YFLogxK
U2 - 10.1097/HJH.0b013e328360381d
DO - 10.1097/HJH.0b013e328360381d
M3 - Article
C2 - 23552122
AN - SCOPUS:84877584908
SN - 0263-6352
VL - 31
SP - 1203
EP - 1213
JO - Journal of Hypertension
JF - Journal of Hypertension
IS - 6
ER -